FDA Ðại afatinib signs to previously untreated, metastatic NSCLC other EGFR mutation not subject

preview_player
Показать описание
FDA Ðại afatinib signs to previously untreated, metastatic NSCLC other EGFR mutation not subject
-----------------------------------------
Thanks for watching video.
  1. Love Later Life
  2. FDA broadens afatinib
  3. broadens afatinib indication
  4. afatinib indication to
  5. indication to previously
  6. to previously untreated
Рекомендации по теме
FDA Ðại afatinib 0:00:11

FDA Ðại afatinib signs to previously untreated, metastatic NSCLC other EGFR mutation not subject

FDA Ðại afatinib 0:00:11

FDA Ðại afatinib signs to previously untreated, metastatic NSCLC other EGFR mutation not subject

Dr. West on 0:01:47

Dr. West on FDA Approval of Afatinib in NSCLC With Rare EGFR Mutations

Side Effect Management 0:03:08

Side Effect Management With Afatinib

How Lung Cancer 0:02:57

How Lung Cancer Drug Treatment Gilotrif (Afatinib) Works

Afatinib inhibits EGFR 0:00:17

Afatinib inhibits EGFR Receptor activation

Medicines videos 0:00:15

Medicines videos

Sequential treatment with 0:06:28

Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive NSCLC

Afatinib: Dose Modifications 0:02:34

Afatinib: Dose Modifications and Adverse Events

Dr. Tolba on 0:01:59

Dr. Tolba on the Use of Afatinib in NRG1-Mutated Lung Adenocarcinoma

GioTag: real world 0:02:34

GioTag: real world data on first-line afatinib followed by osimertinb

Velcheti Gilotrif/ Afatinib 0:04:09

Velcheti Gilotrif/ Afatinib in Squamous NSCLC

How, when, and 0:17:27

How, when, and where to utilize erlotinib, afatinib, and gefitinib in EGFR positive NSCLC

The role of 0:02:49

The role of afatinib in patients with EGFR+ NSCLC

Advances in Frontline 0:08:11

Advances in Frontline Therapy for EGFR+ NSCLC

32nd JACBS in 0:11:23

32nd JACBS in Taiwan, ROC (20170325) (afatinib)

Emerging Data in 0:07:08

Emerging Data in EGFR-Mutant Lung Cancer

Treatment of metastatic 0:03:35

Treatment of metastatic CRC with apatinib - ID 148412

Xovoltib 40mg Tablets 0:00:46

Xovoltib 40mg Tablets Leading Suppliers in India • Matoshree Pharma Chem

Boehringer Ingelheim | 0:02:09

Boehringer Ingelheim | GIOTRIF | Projekt-/Produktfilm

Dr. Padda on 0:01:43

Dr. Padda on Overcoming Resistance to Osimertinib in EGFR+ NSCLC

Estudos comentados por 0:03:35

Estudos comentados por Dr. Mauro Zukin

Lung Cancer: New 0:02:18

Lung Cancer: New Target A Specific Gene

Chemofit 250Mg Tablets 0:00:47

Chemofit 250Mg Tablets Leading Suppliers in India • Matoshree Pharma Chem